Format

Send to

Choose Destination
Methods. 2016 Oct 15;109:190-202. doi: 10.1016/j.ymeth.2016.07.008. Epub 2016 Jul 12.

In situ production of ROS in the skin by photodynamic therapy as a powerful tool in clinical dermatology.

Author information

1
Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, Spain; Grupo de Dermatología Experimental y Biología Cutánea, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, Spain.
2
Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, Spain.
3
Grupo de Dermatología Experimental y Biología Cutánea, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Universitario Ramón y Cajal, Madrid, Spain.
4
Laboratorio de Bionanotecnolgía, Universidad Bernardo ÓHiggins, Santiago, Chile. Electronic address: jespada@iib.uam.es.
5
Servicio de Dermatología, Hospital Universitario Ramón y Cajal, Madrid, Spain. Electronic address: pedro@pjaen.com.

Abstract

Photodynamic therapy (PDT) is a clinical modality of photochemotherapy based on the accumulation of a photosensitizer in target cells and subsequent irradiation of the tissue with light of adequate wavelength promoting reactive oxygen species (ROS) formation and cell death. PDT is used in several medical specialties as an organ-specific therapy for different entities. In this review we focus on the current dermatological procedure of PDT. In the most widely used PDT protocol in dermatology, ROS production occurs by accumulation of the endogenous photosensitizer protoporphyrin IX after treatment with the metabolic precursors 5-methylaminolevulinic acid (MAL) or 5-aminolevulinic acid (ALA). To date, current approved dermatological indications of PDT include actinic keratoses (AK), basal cell carcinoma (BCC) and in situ squamous cell carcinoma (SCC) also known as Bowen disease (BD). With regards to AKs, PDT can also treat the cancerization field carrying an oncogenic risk. In addition, an increasing number of pathologies, such as other skin cancers, infectious, inflammatory or pilosebaceous diseases are being considered as potentially treatable entities with PDT. Besides the known therapeutic properties of PDT, there is a modality used for skin rejuvenation and aesthetic purposes defined as photodynamic photorejuvenation. This technique enables the remodelling of collagen, which in turn prevents and treats photoaging stygmata. Finally we explore a new potential treatment field for PDT determined by the activation of follicular bulge stem cells caused by in situ ROS formation.

KEYWORDS:

Clinical indications; Dermatology; Photorejuvenation; Protoporphyrin-IX; Reactive oxygen species; Tissue regeneration

PMID:
27422482
DOI:
10.1016/j.ymeth.2016.07.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center